亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Stem cell‐derived exosomes in the treatment of melasma and its percutaneous penetration

黄褐斑 医学 经皮 渗透(战争) 治疗效果 间充质干细胞 皮肤病科 外科 病理 运筹学 工程类
作者
Ting Wang,Hangqi Gao,Dezhi Wang,Chaoyu Zhang,Kailun Hu,Shouxin Zhang,Jian Lin,Xiaosong Chen
出处
期刊:Lasers in Surgery and Medicine [Wiley]
卷期号:55 (2): 178-189 被引量:11
标识
DOI:10.1002/lsm.23628
摘要

Melasma is a refractory skin disease due to its complex pathogenesis and difficult treatment. Studies have found that human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) could serve as a novel cell-free therapeutic strategy in regenerative and esthetic medicine. It could potentially treat melasma, but the skin barrier is a challenge. In this study, we aim to explore the safety and efficacy of hUCMSC-Exos in the treatment of melasma and the means to promote its percutaneous penetration.In the animal study about the effect of penetration, percutaneous penetration of PKH67-labeled hUCMSC-Exos was studied under microneedles, 1565 nm nonablative fractional laser (NAFL), and a plasma named Peninsula Blue Aurora Shumin Master (PBASM) treatments, observed by confocal laser scanning microscopy. In the clinical application study, 60 patients with melasma treated in our department were divided into four groups. NAFL combined with normal saline treatment was used for Group A. Microneedles, NAFL, and PBASM combined with hUCMSC-Exos treatments were used for Groups B, C, and D, respectively. Each patient received four treatments at 1-month intervals. Assessments were done using the degree of pain posttreatment, melasma area and severity score, improvement rate, physician global assessment score, satisfaction, and complications.In the animal study about the effect of penetration, hUCMSC-Exos can penetrate the deep dermis under microneedles, NAFL, and PBASM treatments. In the clinical application study, compared with Group A, Groups B, C, and D showed significantly improved therapeutic effect and patient satisfaction (p < 0.05), and there was no significant difference among Groups B, C, and D.(p > 0.05). Patients in Group B reported higher pain levels than those in the other three groups (p < 0.05); the treatment experience of patients in Group D was better.hUCMSC-Exos can improve the symptoms of melasma safely and effectively. Compared with microneedles, NAFL and PBASM can also achieve a good effect toward promoting penetration. These findings are worthy of exploration and clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
ok完成签到 ,获得积分10
3秒前
5秒前
linjiaxin完成签到,获得积分10
6秒前
半糖神仙发布了新的文献求助10
9秒前
sallltyyy完成签到 ,获得积分10
28秒前
Ava应助半糖神仙采纳,获得30
33秒前
CipherSage应助Quinta采纳,获得10
45秒前
爱静静应助科研通管家采纳,获得30
53秒前
大个应助科研通管家采纳,获得10
53秒前
啥名都行完成签到,获得积分10
53秒前
53秒前
科研通AI2S应助科研通管家采纳,获得10
53秒前
53秒前
Quinta完成签到,获得积分10
55秒前
59秒前
1分钟前
Quinta发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
pathway发布了新的文献求助10
1分钟前
1分钟前
Uncanny完成签到,获得积分10
1分钟前
pathway完成签到,获得积分10
1分钟前
2分钟前
大桃完成签到,获得积分10
2分钟前
shenhai发布了新的文献求助10
2分钟前
凌代萱完成签到 ,获得积分10
2分钟前
大模型应助医路通行采纳,获得10
2分钟前
2分钟前
犹豫傲南完成签到 ,获得积分10
2分钟前
3分钟前
所所应助对流域采纳,获得10
3分钟前
3分钟前
3分钟前
舒适怀寒完成签到 ,获得积分10
3分钟前
check003完成签到,获得积分10
3分钟前
3分钟前
对流域发布了新的文献求助10
3分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137011
求助须知:如何正确求助?哪些是违规求助? 2787960
关于积分的说明 7784078
捐赠科研通 2444023
什么是DOI,文献DOI怎么找? 1299627
科研通“疑难数据库(出版商)”最低求助积分说明 625497
版权声明 600989